Overview

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Status:
Terminated

Trial end date:
2013-10-31

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the safety and tolerability of long term (6 months) armodafinil treatment as adjunctive therapy to mood-stabilizing medications in adults with bipolar I disorder.

Phase:

Phase 3

Details

Lead Sponsor:

Cephalon

Treatments:

Armodafinil
Modafinil